RHOFADE
Peakoxymetazoline hydrochloride
NDATOPICALCREAM
Approved
Jan 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1
Clinical Trials (1)
A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"
Started Apr 2019
1,105 enrolled
Rosacea
Loss of Exclusivity
LOE Date
Jun 11, 2035
112 months away
Patent Expiry
Jun 11, 2035